PUTNAM INVESTMENTS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$338,368
-85.9%
5,647
-77.6%
0.00%
-80.0%
Q3 2020$2,404,000
-57.5%
25,225
-50.1%
0.01%
-58.3%
Q2 2020$5,658,000
+219.8%
50,592
+107.9%
0.01%
+140.0%
Q1 2020$1,769,000
-54.7%
24,329
-35.1%
0.01%
-37.5%
Q4 2019$3,909,000
+4.8%
37,4830.0%0.01%0.0%
Q3 2019$3,731,000
-18.4%
37,483
-6.4%
0.01%
-20.0%
Q2 2019$4,574,000
-9.2%
40,0650.0%0.01%
-16.7%
Q1 2019$5,036,000
-23.9%
40,065
-17.9%
0.01%
-29.4%
Q4 2018$6,621,000
-50.6%
48,7880.0%0.02%
-41.4%
Q3 2018$13,392,000
+60.9%
48,788
+21.4%
0.03%
+222.2%
Q2 2018$8,324,000
+99.4%
40,178
+59.0%
0.01%
-10.0%
Q1 2018$4,174,000
-22.4%
25,272
-35.6%
0.01%
+66.7%
Q4 2017$5,376,000
+99.7%
39,254
+98.5%
0.01%0.0%
Q3 2017$2,692,000
+85.8%
19,772
+44.4%
0.01%
+100.0%
Q1 2017$1,449,000
-6.9%
13,688
-10.7%
0.00%
-25.0%
Q4 2016$1,557,000
-0.9%
15,324
-0.5%
0.00%0.0%
Q3 2016$1,571,000
-46.3%
15,396
-37.2%
0.00%
-42.9%
Q2 2016$2,924,000
+77.1%
24,518
+59.0%
0.01%
+75.0%
Q1 2016$1,651,000
+0.7%
15,421
+2.1%
0.00%0.0%
Q4 2015$1,639,000
+23.9%
15,111
-2.1%
0.00%
+33.3%
Q3 2015$1,323,000
-12.6%
15,438
+3.0%
0.00%0.0%
Q2 2015$1,513,000
+30.3%
14,990
-0.5%
0.00%
+50.0%
Q1 2015$1,161,00015,0670.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders